Uncategorized

All cancer patients or those with a history of cancer should be eligible for COVID-19 vaccine trials and other clinical trials, unless there is credible risk of harm from participation, the American Society of Clinical Oncology said June 23. 

Greenville, S.C.-based Prisma Health has entered a 10-year strategic partnership with Siemens Healthineers focused on scaling healthcare innovation, improving workforce development and launching a joint intelligence center, the organizations announced June 22. 

Just 12.9 percent of eligible Medicare and Medicaid patients were screened for lung cancer between 2019-2021, despite having insurance coverage, according to a recent analysis of data from Epic's Health Research Network. 

The Mississippi State Department of Health has partnered with a patient engagement platform to provide free cancer survivorship services to qualifying state residents. 

University Hospitals in Cleveland became one of the first in the U.S. to treat a heart failure patient using cardiac contractility modulation, or CCM, a novel therapy meant to improve heart contractions. 

The American Academy of Pediatrics now says all children should be screened for conditions that can lead to cardiac arrest or death — a reversal from 2012 guidance that mainly focused on children who play sports.

Dr. Joseph Carrozza, MD, vice president of cardiovascular medicine at Dallas-based Steward Health Care, discussed why physicians should never stop reading clinical literature and the benefits of taking ownership of patients' care during a recent episode of the Becker's Healthcare…

To move the needle on innovative treatment approaches within cardiology, the field must avoid over reliance on traditional approaches, says Angel Leon, MD, co-director of Atlanta-based Emory Heart and Vascular Institute. 

West Orange, N.J.-based RWJBarnabas Health and the Rutgers Cancer Institute of New Jersey will break ground on a $750 million cancer facility June 24. 

Of 423 encounters between oncologists and patients, just 5 percent included end-of-life discussions, with oncologists often shying away from such conversations even when the opportunity presented itself, according to findings recently published in JAMA Network Open.